Clinical Trial Update: Sleep Inducing And Maintaining Efficacy Of Circadin In Elderly Insomniacs [Phase 2]

View source ↗

Summary

A Phase 2 trial by Neurim Pharmaceuticals evaluating Circadin (melatonin) for sleep induction and maintenance in elderly patients with primary insomnia has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• Circadin (melatonin)

Snippet

Sponsor: Neurim Pharmaceuticals Ltd. | Conditions: Primary Insomnia | Phase 2 | Status: COMPLETED